These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5942021)
1. [Comparison of the effect of iproniazid, methylene blue and benactyzine on angina pectoris]. Rysánek K; Svehla O; Vítek V Cas Lek Cesk; 1966 Jun; 105(22):591-7. PubMed ID: 5942021 [No Abstract] [Full Text] [Related]
2. [Monoaminoxidase inhibitors in the treatment of angina pectoris]. Kushelevskiĭ BP; Kokosov AN Sov Med; 1967 Apr; 30(4):24-9. PubMed ID: 5608571 [No Abstract] [Full Text] [Related]
3. INTERPRETATION OF THE PSYCHOSTIMULATING EFFECT OF METHYLENE BLUE. RYSANEK K; VITEK V; VOJTECHOVSKY M Act Nerv Super (Praha); 1964; 6():74-6. PubMed ID: 14140599 [No Abstract] [Full Text] [Related]
4. [Treatment of stenocardia in hypertension]. Kushelevskiĭ BP; Kokosov AN Ter Arkh; 1968 Mar; 40(3):47-51. PubMed ID: 5669283 [No Abstract] [Full Text] [Related]
5. [Experience with Iprazid treatment of patients with stenocardia]. Klimenko AG; Tsymbaliuk VP Vrach Delo; 1968 May; 5():70-3. PubMed ID: 5740462 [No Abstract] [Full Text] [Related]
6. [Therapy of angina pectoris. 3. Papaverine, xanthine and other drugs]. Messini M Clin Ter; 1974 Feb; 68(3):205-31. PubMed ID: 4824574 [No Abstract] [Full Text] [Related]
7. [On marsilid-therapy in angina pectoris and peripheral circulatory disorders]. ISLER U Cardiologia (Basel); 1959; 35(Suppl)():38-45. PubMed ID: 14405945 [No Abstract] [Full Text] [Related]
8. Antianginal drugs. V. Monoamine oxidase (MAO) inhibitors. Fisch S Am Heart J; 1966 Jun; 71(6):837-8. PubMed ID: 5945147 [No Abstract] [Full Text] [Related]
9. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome]. Cristiano P; Panzitta S; Cuiuli V; Petronio A; Giraldi A Minerva Gastroenterol; 1973; 19(4):259-69. PubMed ID: 4592525 [No Abstract] [Full Text] [Related]
10. [Electroencephalographic analysis of the effect of some neurotropic drugs on the mediator brain structures in patients with Kozhevnikov's epilepsy]. Strokina TI Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(11):1671-8. PubMed ID: 4252343 [No Abstract] [Full Text] [Related]
11. [Comparative clinico-physiological study of the effect of several MAO inhibitors in stenocardia]. Barats SS; Oranskiĭ IE; Kartashova DI; Gorovater EN Kardiologiia; 1976 Mar; 16(3):138-40. PubMed ID: 1021625 [No Abstract] [Full Text] [Related]
12. [Some problems of the differentiated pathogenic therapy of angina pectoris of varied origin]. Kushelevskiĭ BP; Kokosov AN Kardiologiia; 1968 Jul; 8(7):46-50. PubMed ID: 4386948 [No Abstract] [Full Text] [Related]
13. [EFFECT OF METHYLENE BLUE ON ANGINA PECTORIS]. DVORAK L; VANCURA P; VOSLAROVA Z Cas Lek Cesk; 1965 Feb; 104():175-81. PubMed ID: 14308253 [No Abstract] [Full Text] [Related]
14. Methylene blue in anaphylactic shock. Evora PR; Roselino CH; Schiaveto PM Ann Emerg Med; 1997 Aug; 30(2):240. PubMed ID: 9250657 [No Abstract] [Full Text] [Related]
15. [On the effect of iproniazid ('marsilid') in 50 cases of angina pectoris]. ZBINDEN J; MOESCHLIN S Cardiologia (Basel); 1959; 35(Suppl)():62-86. PubMed ID: 13847127 [No Abstract] [Full Text] [Related]
16. [Use of iproniazid in angina pectoris]. PHILOCREON DR Hospital (Rio J); 1959 Jul; 56():137-40. PubMed ID: 14432647 [No Abstract] [Full Text] [Related]
17. [Iproniazid in the treatment of angina pectoris: clinical research with "double blind" experimentation]. FASOLI A; BINDA G; PRIORE P Mal Cardiovasc; 1962 Dec; 3():551-63. PubMed ID: 13944496 [No Abstract] [Full Text] [Related]